Zhe Jiang Dayang Biotech Group Co., Ltd.

SZSE:003017 Stock Report

Market Cap: CN¥1.6b

Zhe Jiang Dayang Biotech Group Past Earnings Performance

Past criteria checks 2/6

Zhe Jiang Dayang Biotech Group's earnings have been declining at an average annual rate of -9.2%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 10.3% per year. Zhe Jiang Dayang Biotech Group's return on equity is 5.9%, and it has net margins of 7%.

Key information

-9.2%

Earnings growth rate

-15.6%

EPS growth rate

Chemicals Industry Growth12.1%
Revenue growth rate10.3%
Return on equity5.9%
Net Margin7.0%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

The Returns On Capital At Zhe Jiang Dayang Biotech Group (SZSE:003017) Don't Inspire Confidence

Sep 28
The Returns On Capital At Zhe Jiang Dayang Biotech Group (SZSE:003017) Don't Inspire Confidence

Zhe Jiang Dayang Biotech Group Co., Ltd.'s (SZSE:003017) Shares Bounce 31% But Its Business Still Trails The Market

Mar 08
Zhe Jiang Dayang Biotech Group Co., Ltd.'s (SZSE:003017) Shares Bounce 31% But Its Business Still Trails The Market

Revenue & Expenses Breakdown

How Zhe Jiang Dayang Biotech Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:003017 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24877617330
30 Jun 24875587535
31 Mar 24863487537
31 Dec 23919507439
30 Sep 231,038718139
30 Jun 231,047677533
31 Mar 231,115927036
01 Jan 231,058816834
30 Sep 22951516736
30 Jun 22890556639
31 Mar 22801536430
31 Dec 21783706428
30 Sep 21750846025
30 Jun 21742926122
31 Mar 21719965622
31 Dec 20678925422
30 Sep 206641014921
30 Jun 20629925121
31 Mar 20600815619
31 Dec 19622795920
30 Sep 19598736118
30 Jun 19605725916
31 Mar 19590725323
01 Jan 19584715918
01 Oct 18599686713
30 Jun 1861366758
31 Mar 1859058800
31 Dec 1755550760
30 Sep 17500446412
30 Jun 1744537765
31 Mar 1744133800
01 Jan 1744129750
30 Sep 1645430720
30 Jun 1646632690
31 Mar 1645728700
01 Jan 1644824720
01 Jan 1545928720
31 Dec 1350026680

Quality Earnings: 003017 has high quality earnings.

Growing Profit Margin: 003017's current net profit margins (7%) are higher than last year (6.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 003017's earnings have declined by 9.2% per year over the past 5 years.

Accelerating Growth: 003017's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 003017 had negative earnings growth (-13.7%) over the past year, making it difficult to compare to the Chemicals industry average (-4.7%).


Return on Equity

High ROE: 003017's Return on Equity (5.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 02:06
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zhe Jiang Dayang Biotech Group Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution